Acurx Pharmaceuticals (ACXP) Misses Q2 EPS by 5c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.28), $0.05 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• Biogen expects $164M R&D charge to hit Q2 2026 earnings
• Columbus McKinnon names John Linker as CFO, reaffirms FY2027 guidance